Access

Article


Nature Medicine 8, 358 - 365 (2002)
doi:10.1038/nm0402-358

CD39 is the dominant Langerhans cell–associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness

Norikatsu Mizumoto1,3, Tadashi Kumamoto1,3, Simon C. Robson2, Jean Sévigny2, Hiroyuki Matsue1, Keiichi Enjyoji2 & Akira Takashima1


CD39, the endothelial ecto-nucleoside triphosphate diphosphohydrolase (NTPDase), regulates vascular inflammation and thrombosis by hydrolyzing ATP and ADP. Although ecto-NTPDase activities have been used as a marker of epidermal dendritic cells (DCs) known as Langerhans cells, the identity and function of these activities remain unknown. Here we report that Langerhans cells in CD39-/- mice express no detectable ecto-NTPDase activity. Irritant chemicals triggered rapid ATP and ADP release from keratinocytes and caused exacerbated skin inflammation in CD39-/- mice. Paradoxically, T cell–mediated allergic contact hypersensitivity was severely attenuated in CD39-/- mice. As to mechanisms, T cells increased pericellular ATP concentrations upon activation, and CD39-/- DCs showed ATP unresponsiveness (secondary to P2-receptor desensitization) and impaired antigen-presenting capacity. Our results show opposing outcomes of CD39 deficiency in irritant versus allergic contact dermatitis, reflecting its diverse roles in regulating extracellular nucleotide-mediated signaling in inflammatory responses to environmental insults and DC–T cell communication in antigen presentation.


MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

NEWS AND VIEWS
The skinny on CD39 in immunity and inflammation
Nature Medicine News and Views (01 Apr 2002)
Nucleotides and cd39: Principal modulatory players in hemostasis and thrombosis
Nature Medicine News and Views (01 Sep 1999)

RESEARCH
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
Nature Medicine Article (01 Sep 1999)